We have extensive expertise in analytical method development. We can develop a method from scratch or transfer and optimize an existing method, providing consistent and reliable results as a product progresses through the clinic and delivering cGMP compliant documents to support regulatory filing.
We support early phase development as part of your IND or optimize methods developed by your API or BDS vendor. We can enhance assays to their required phase to include additional potency, purity or excipient analysis.
Streamlined Testing at Every Phase
- Drug substance/API identification & release testing
- Drug product in-process, release, and stability
- Raw materials – excipients and intermediates
- Reference standard qualification
- Cleaning method development and verification/validation
- Forced degradation studies
- Impurity profiling
- Material compatibility
- Spike and recovery Studies
Analytical Method Qualification and Validation
Existing methods transferred in and methods we develop in-house are validated according to phase appropriate approaches for cGMP use, and support in-process, release and/or stability testing.
Our dedicated team of specialists will be happy to discuss our Analytical Method Development services with you. Contact us on +1 779-208-1819 (US) or +44 1495 711 222 (UK/EU) or email firstname.lastname@example.org
Start your PCI experience today.
Rely on our analytical method development services. Your drug product destination means the world to us.
A world of sterile manufacturing awaits
We provide integrated large and small-molecule solutions for clinical and commercial projects, and with over 20 years in the sterile fill-finish and lyophilization manufacturing space, we are dedicated to your success in bringing life-changing therapies to patients.
September 13, 2022
August 22, 2022
July 15, 2022